User profiles for J. R. Perry
James PerryProfessor of Neurology, University of Toronto Verified email at sunnybrook.ca Cited by 12534 |
Standards of care for treatment of recurrent glioblastoma—are we there yet?
Newly diagnosed glioblastoma is now commonly treated with surgery, if feasible, or biopsy,
followed by radiation plus concomitant and adjuvant temozolomide. The treatment of …
followed by radiation plus concomitant and adjuvant temozolomide. The treatment of …
The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence‐based review
LC Marras, WH Geerts, JR Perry - Cancer, 2000 - Wiley Online Library
BACKGROUND Venous thromboembolism (VTE) frequently complicates the course of
patients with cancer, and there is evidence to suggest that patients with brain tumors are at …
patients with cancer, and there is evidence to suggest that patients with brain tumors are at …
Optimal management of elderly patients with glioblastoma
N Laperriere, M Weller, R Stupp, JR Perry… - Cancer treatment …, 2013 - Elsevier
Median age at diagnosis in patients with glioblastoma (GB) is slowly increasing with an aging
population in Western countries, and was 64years in 2006. The number of patients age 65 …
population in Western countries, and was 64years in 2006. The number of patients age 65 …
[HTML][HTML] Vorasidenib in IDH1-or IDH2-mutant low-grade glioma
Background Isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas are malignant brain
tumors that cause considerable disability and premature death. Vorasidenib, an oral brain-…
tumors that cause considerable disability and premature death. Vorasidenib, an oral brain-…
[HTML][HTML] Short-course radiation plus temozolomide in elderly patients with glioblastoma
JR Perry, N Laperriere, CJ O'Callaghan… - … England Journal of …, 2017 - Mass Medical Soc
Background Glioblastoma is associated with a poor prognosis in the elderly. Survival has
been shown to increase among patients 70 years of age or younger when temozolomide …
been shown to increase among patients 70 years of age or younger when temozolomide …
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
…, JY Smith, S Blackmore, S Sanisetty, JR Perry… - Nature, 2013 - nature.com
Human immunodeficiency virus type 1 (HIV-1)-specific monoclonal antibodies with extraordinary
potency and breadth have recently been described. In humanized mice, combinations …
potency and breadth have recently been described. In humanized mice, combinations …
An evaluation of the effectiveness of adaptive histogram equalization for contrast enhancement
…, SM Pizer, EV Staab, JR Perry… - … on Medical Imaging, 1988 - ieeexplore.ieee.org
Adaptive histogram equalization (AHE) and intensity windowing have been compared using
psychophysical observer studies. Experienced radiologists were shown clinical CT (…
psychophysical observer studies. Experienced radiologists were shown clinical CT (…
[HTML][HTML] Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys
…, AM Riggs, DM Lynch, SL Clark, K Backus, JR Perry… - Nature medicine, 2010 - nature.com
The worldwide diversity of HIV-1 presents an unprecedented challenge for vaccine
development 1 , 2 . Antigens derived from natural HIV-1 sequences have elicited only a limited …
development 1 , 2 . Antigens derived from natural HIV-1 sequences have elicited only a limited …
The rising rate of rural hospital closures
…, SR Thomas, RK Randolph, JR Perry… - The Journal of rural …, 2016 - Wiley Online Library
Purpose Since 2010, the rate of rural hospital closures has increased significantly. This study
is a preliminary look at recent closures and a formative step in research to understand the …
is a preliminary look at recent closures and a formative step in research to understand the …
[PDF][PDF] Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study
… Perry et al25 used continuous TMZ 50 mg/m2 in patients with recurrent malignant glioma.
Six-month PFS in patients with GBM who experienced progression on the TMZ 5/28 schedule …
Six-month PFS in patients with GBM who experienced progression on the TMZ 5/28 schedule …